| id | C00023662 |
|---|---|
| Name | Alternariol monomethyl ether / 3,4'-Dihydroxy-5-methoxy-6'-methyldibenzo[a]pyrone |
| CAS RN | 23452-05-3 |
| Standard InChI | InChI=1S/C15H12O5/c1-7-3-8(16)4-12-13(7)10-5-9(19-2)6-11(17)14(10)15(18)20-12/h3-6,16-17H,1-2H3 |
| Standard InChI (Main Layer) | InChI=1S/C15H12O5/c1-7-3-8(16)4-12-13(7)10-5-9(19-2)6-11(17)14(10)15(18)20-12/h3-6,16-17H,1-2H3 |
| Phytochemical cluster | No. 17 |
|---|---|
| KCF-S cluster | No. 54 |
| By standard InChI | CHEMBL483526 |
|---|---|
| By standard InChI Main Layer | CHEMBL483526 |
| By LinkDB |
|---|
| By CAS RN | C018206 |
|---|
| class name | count |
|---|
| family name | count |
|---|---|
| Pleosporaceae | 3 |
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Alternaria cucumerina | 283358 | Pleosporaceae | Fungi | |
| Alternaria dauci | 48095 | Pleosporaceae | Fungi | |
| Alternaria tenuis NRRL 5831 | 5598 | Pleosporaceae | Fungi |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P08069 | Insulin-like growth factor 1 receptor | TK tyrosine-protein kinase INSR subfamily | CHEMBL483526 |
CHEMBL962870
(1)
|
1 / 3 |
| O14965 | Aurora kinase A | Aur | CHEMBL483526 |
CHEMBL966176
(1)
|
0 / 0 |
| P68400 | Casein kinase II subunit alpha | Ck2 | CHEMBL483526 |
CHEMBL962879
(1)
|
0 / 0 |
| P24941 | Cyclin-dependent kinase 2 | Cdc2 | CHEMBL483526 |
CHEMBL966179
(1)
|
0 / 0 |
| O00444 | Serine/threonine-protein kinase PLK4 | PLK serine/threonine protein kinase subfamily | CHEMBL483526 |
CHEMBL966209
(1)
|
0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL483526 |
CHEMBL962866
(1)
|
1 / 11 |
| P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | CHEMBL483526 |
CHEMBL962874
(1)
|
1 / 1 |
| P54760 | Ephrin type-B receptor 4 | Eph | CHEMBL483526 |
CHEMBL962867
(1)
|
0 / 0 |
| Q05397 | Focal adhesion kinase 1 | Fak | CHEMBL483526 |
CHEMBL962869
(1)
|
0 / 0 |
| Q02763 | Angiopoietin-1 receptor | Tie | CHEMBL483526 |
CHEMBL965366
(1)
|
1 / 1 |
| O60285 | NUAK family SNF1-like kinase 1 | CAMK serine/threonine protein kinase NUAK subfamily | CHEMBL483526 |
CHEMBL966175
(1)
|
0 / 0 |
| P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | CHEMBL483526 |
CHEMBL962875
(1)
|
5 / 4 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL483526 |
CHEMBL962868
(1)
|
5 / 10 |
| P09619 | Platelet-derived growth factor receptor beta | Pdgfr | CHEMBL483526 |
CHEMBL962877
(1)
|
5 / 1 |
| P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | CHEMBL483526 |
CHEMBL962871
(1)
|
0 / 0 |
| Q96GD4 | Aurora kinase B | Aur | CHEMBL483526 |
CHEMBL966177
(1)
|
0 / 0 |
| P35968 | Vascular endothelial growth factor receptor 2 | Vegfr | CHEMBL483526 |
CHEMBL962872
(1)
|
1 / 0 |
| P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | CHEMBL483526 |
CHEMBL962876
(1)
|
2 / 3 |
| P35916 | Vascular endothelial growth factor receptor 3 | Vegfr | CHEMBL483526 |
CHEMBL962873
(1)
|
2 / 1 |
| P41279 | Mitogen-activated protein kinase kinase kinase 8 | Ste11 | CHEMBL483526 |
CHEMBL966181
(1)
|
0 / 0 |
| P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | CHEMBL483526 |
CHEMBL962878
(1)
|
0 / 0 |
| P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL483526 |
CHEMBL966174
(1)
|
4 / 1 |
| P11802 | Cyclin-dependent kinase 4 | CMGC serine/threonine protein kinase family | CHEMBL483526 |
CHEMBL966180
(1)
|
1 / 3 |
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| C018206 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | alternariol monomethyl ether results in increased activity of CASP3 protein |
increases activity
|
protein |
22001388
|
| C018206 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | alternariol monomethyl ether results in increased activity of CASP9 protein |
increases activity
|
protein |
22001388
|
| C018206 | 2938 |
GSTA1
GST2 GSTA1-1 GTH1 |
glutathione S-transferase alpha 1 (EC:2.5.1.18) | alternariol monomethyl ether affects the localization of GSTA1 mRNA |
affects localization
|
mRNA |
23154127
|
| C018206 | 2939 |
GSTA2
GST2 GSTA2-2 GTA2 GTH2 |
glutathione S-transferase alpha 2 (EC:2.5.1.18) | alternariol monomethyl ether affects the localization of GSTA2 mRNA |
affects localization
|
mRNA |
23154127
|
| C018206 | 4780 |
NFE2L2
NRF2 |
nuclear factor, erythroid 2-like 2 | alternariol monomethyl ether affects the localization of NFE2L2 protein |
affects localization
|
protein |
23154127
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #615007 | Basal ganglia calcification, idiopathic, 4; ibgc4 |
P09619
|
| #114480 | Breast cancer |
P31749
|
| #114500 | Colorectal cancer; crc |
P31749
|
| #615109 | Cowden syndrome 6; cws6 |
P31749
|
| #610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
| #125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
| #246200 | Donohue syndrome |
P06213
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #602089 | Hemangioma, capillary infantile |
P35916
P35968 |
| #114550 | Hepatocellular carcinoma |
P08581
|
| #609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
| #270450 | Insulin-like growth factor i, resistance to |
P08069
|
| #607785 | Juvenile myelomonocytic leukemia; jmml |
P09619
|
| #601626 | Leukemia, acute myeloid; aml |
P09619
P36888 |
| #211980 | Lung cancer |
P00533
P04626 |
| #153100 | Lymphedema, hereditary, ia |
P35916
|
| #609048 | Melanoma, cutaneous malignant, susceptibility to, 3; cmm3 |
P11802
|
| #131440 | Myeloproliferative disorder, chronic, with eosinophilia |
P09619
|
| #228550 | Myofibromatosis, infantile, 1; imf1 |
P09619
|
| #167000 | Ovarian cancer |
P04626
|
| #262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
| #176920 | Proteus syndrome |
P31749
|
| #605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
| #600195 | Venous malformations, multiple cutaneous and mucosal; vmcm |
Q02763
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
|
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P08581 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) P11802 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P09619 (related) P11802 (related) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00026 | Endometrial Cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
|
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P08581 (related) |
| H00719 | Leprechaunism |
P06213
(related)
|
| H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
| H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
| H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
| H00015 | Malignant pleural mesothelioma |
P08069
(related)
|
| H00050 | Synovial sarcoma |
P08069
(related)
|
| H01274 | Growth delay due to insulin-like growth factor I resistance |
P08069
(related)
|
| H00021 | Renal cell carcinoma |
P08581
(related)
|
| H00038 | Malignant melanoma |
P11802
(related)
|
| H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
| H00535 | Lymphedemas |
P35916
(related)
|
| H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
|
| H00531 | Venous malformations |
Q02763
(related)
|